Company / Current Liabilities
Olema Pharmaceuticals, Inc. Current Liabilities History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$41.8M
FY2024
5-year range
$4.6M / $41.8M
FY2020-FY2024
Trend
+93.1%
vs FY2023
Sector context
#158 of 213
Health Care
What the data says
At $42M, Olema Pharmaceuticals, Inc.'s current liabilities ranks #56 of 213 in the Health Care sector. Current Liabilities has increased for 4 consecutive years, from $5M in FY2020 to $42M in FY2024.
Based on SEC 10-K filings.
$42M in FY2024 with a 3-year CAGR of +66.7%.
Increased from $17M to $42M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +66.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#56 of 213 in Health CareTop 26% of 213This company $41.8M Sector average $1.6B
▼
-97.4% below sector average
Key checks
Key Insights
- Olema Pharmaceuticals, Inc.'s current liabilities has grown for 4 consecutive years.
- 3-year CAGR of +66.7%, indicating consistent growth.
- In FY2024, current liabilities increased 93.1% year-over-year.
- Ranks #158 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $41.8M | +93.1% |
| FY2023 | $21.6M | +30.6% |
| FY2022 | $16.5M | +83.5% |
| FY2021 | $9.0M | +96.7% |
| FY2020 | $4.6M | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026